Inhibitor potency varies widely among tumor-relevant human isocitrate dehydrogenase 1 mutants.
Avellaneda Matteo D, Wells GA, Luna LA, Grunseth AJ, Zagnitko O, Scott DA, Hoang A, Luthra A, Swairjo MA, Schiffer JM, Sohl CD.
Avellaneda Matteo D, et al. Among authors: sohl cd.
Biochem J. 2018 Oct 22;475(20):3221-3238. doi: 10.1042/BCJ20180424.
Biochem J. 2018.
PMID: 30249606
Free PMC article.